MediWound Ltd.
MDWD
$18.03
-$0.12-0.66%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 12.74% | 9.40% | 6.08% | 30.67% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 12.74% | 9.40% | 6.08% | 30.67% | |
| Cost of Revenue | -5.42% | 6.88% | 26.95% | 46.55% | |
| Gross Profit | 200.22% | 25.59% | -60.69% | -26.51% | |
| SG&A Expenses | 17.61% | 43.27% | -2.79% | -7.03% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -91.96% | -- | -- | |
| Total Operating Expenses | 19.66% | 26.45% | 8.74% | 6.55% | |
| Operating Income | -27.48% | -48.62% | -11.90% | 14.44% | |
| Income Before Tax | -110.56% | -139.68% | -779.63% | -163.15% | |
| Income Tax Expenses | 2,000.00% | -85.00% | -116.67% | 380.00% | |
| Earnings from Continuing Operations | -111.23% | -124.21% | -788.32% | -163.44% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -111.23% | -124.21% | -788.32% | -163.44% | |
| EBIT | -27.48% | -48.62% | -11.90% | 14.44% | |
| EBITDA | -28.96% | -50.40% | -11.78% | 17.11% | |
| EPS Basic | -80.88% | -91.64% | -782.91% | -139.29% | |
| Normalized Basic EPS | -80.32% | 67.23% | -774.29% | -- | |
| EPS Diluted | -80.88% | -91.64% | -782.91% | -139.29% | |
| Normalized Diluted EPS | -80.32% | 67.23% | -774.29% | -- | |
| Average Basic Shares Outstanding | 16.77% | 17.04% | 0.77% | 10.09% | |
| Average Diluted Shares Outstanding | 16.77% | 17.04% | 0.77% | 10.09% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |